Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

Expanding the phenotypic and genotypic spectrum of KCNT1-related epilepsies

Mathilde Gras, Gaelle Quentin-Romand, Nicole Chemaly, Giulia Barcia, KCNT1 consortium and Rima NabboutNecker Enfants Malades Hospital and Université Paris Cité. France Brain CommunicationsBrain Commun 2026; 8: DOI: 10.1093/braincomms/fcag256 AbstractThe KCNT1 gene encodes for a sodium-activated potassium channel involved in neuronal excitability. Since its initial description in 2012 in patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) […]

Expanding the phenotypic and genotypic spectrum of KCNT1-related epilepsies Read More »

MicroRNA Signatures in Cardiovascular Diseases: A Systematic Literature Review

Hariballav Mahapatra, Pankaj Banotra, Anand Sekar G, Jignesh Sharma, Sharat Vishwanath K, Dinesh TripathiSevayan Diabetes Centre. Sri Jayadeva Institute of Cardiovascular Sciences. Aarupadai Veedu Medical College and Vinayaka Missions Research Foundation. Mansarovar Medical College. Bhopal Memorial Hospital and Research Centre of Bhopal Nursing College. Subharti Medical College.India CureusCureus 2026; 18: DOI: 10.7759/cureus.110938 AbstractCardiovascular diseases remain the

MicroRNA Signatures in Cardiovascular Diseases: A Systematic Literature Review Read More »

Bronchiectasis in Inborn Errors of Immunity: Prevalence, Predictors, and Cardiopulmonary Complications in a Genetically Characterized Cohort

Diana Marangu-Boore, Katherine Myint-Hpu, Esther Kang, Luigi D. Notarangelo, Ottavia M. DelmonteNational Institutes of Health. University of Nairobi. United States and Kenya Journal of Clinical ImmunologyJ Clin Immunol 2026; DOI: 10.1007/s10875-026-02044-8 AbstractPurpose: Bronchiectasis poses a serious but incompletely defined burden in patients with inborn errors of immunity (IEI). We determined its prevalence, independent predictors, and cardiopulmonary complications

Bronchiectasis in Inborn Errors of Immunity: Prevalence, Predictors, and Cardiopulmonary Complications in a Genetically Characterized Cohort Read More »

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis

Yuichi Tamura, Kenya Kusunose, Yugo Yamashita, Teiji Akagi, Masanori Atsukawa, Yoshihiro Fukumoto, Ayumi Goda, Shinya Goto, Masaru Hatano, Masataka Ikeda, Keiichi Ishida, Masaharu Kataoka, Masataka Kuwana, Hiromi Matsubara, Makoto Mo, Tetsutaro Nagaoka, Takeshi Ogo, Yoshinori Okada, Seiichiro Sakao, Hirofumi Sawada, Toshiro Shinke, Nobuhiro Tanabe, Norikazu Yamada, Hiroyuki Yamagishi, Shingo Yano, Kohtaro Abe, Shiro Adachi, Kazuya

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis Read More »

Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure: The RAFT Clinical Trial

Jena L. Miller, Ahmet A. Baschat, Anthony Johnson, Yair J. Blumenfeld, Mauro H. Schenone, Juliana S. Gebb, Julie S. Moldenhauer, Michael V. Zaretsky, Ramen H. Chmait, Juan M. Gonzalez, Russel S. Miller, Eyal Krispin, Alireza Shamshirsaz, Katherine H. Bligard, Amanda M. Kalan, Magdalena Sanz Cortes, Anita J. Moon-Grady, Ellen Bendel-Stenzel, Shina Menon, Cynthia Wong, Paul

Neonatal Survival After Serial Amnioinfusions for Anhydramnios Due to Fetal Kidney Failure: The RAFT Clinical Trial Read More »

Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs

Motoyasu Miura, Shimako Tanaka, Ririka Aihara, Shun Yamamoto, Yasumi Nakashima, Yasuharu Kashiwagura, Akio Hakamata, Sachiko Miyakawa, Mariko Tatsuguchi, Keiichi Odagiri, Noriyuki Namiki, Naoki Inui, Hiroshi Watanabe, Shinya UchidaUniversity of Shizuoka. Seirei Hamamatsu General Hospital. Hamamatsu University School of Medicine.Japan British Journal of Clinical PharmacologyBr J Clin Pharmacol 2026; DOI: 10.1002/bcp.70676 AbstractAims: Pulmonary arterial hypertension (PAH) is a

Development of a population pharmacokinetic model using combined paediatric and adult data for four pulmonary arterial hypertension drugs Read More »

Heart-lung transplantation in the United Kingdom: Trends and outcomes over 4 decades

Miguel Angel Reyes Roque, Emre Erturk, Sally Rushton, Aaron Ranasinghe, Helen Spencer, Alexandra Ball, Debra Thomas, Jasvir Parmar, Vasiliki Gerovasili, Louise Coats, Andrew J. Fisher, Louise A. KennyNHS Blood and Transplant. Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Newcastle University. Queen Elizabeth Hospital, University Hospitals Birmingham NHS Trust. Great Ormond Street Hospital.

Heart-lung transplantation in the United Kingdom: Trends and outcomes over 4 decades Read More »

Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan

Taylor P. Saley, Natalie Villafranco, Megan Griffiths, Kara N. GossUniversity of Texas at Austin Dell Medical School. Baylor College of Medicine and Texas Children’s Hospital. University of Texas Southwestern Medical Center. United States Paediatric Respiratory ReviewsPaediatr Respir Rev 2026; DOI: 10.1016/j.prrv.2026.05.006 AbstractBronchopulmonary dysplasia is a frequent complication of preterm birth and is often associated with the

Bronchopulmonary dysplasia associated pulmonary hypertension: implications across the lifespan Read More »

Recent Advances in Pulmonary Hypertension Management

Sarah P. Cohen Alexandria L. Miller, Saurabh Rajpal, Scott H. VisovattiOhio State University School of Medicine and Nationwide Children’s Hospital. United States Heart Failure ClinicsHeart Fail Clin 2026; 22: 371-385DOI: 10.1016/j.hfc.2026.02.011 AbstractSignificant progress has been made in the management of pulmonary hypertension (PH), and especially pulmonary arterial hypertnesion (PAH), over the last 3 decades. Recent advances

Recent Advances in Pulmonary Hypertension Management Read More »

The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension

Evelyne Bischof, Chaim Haber, Niklas LidströmerShanghai University of Medicine and Health Sciences. Sheba Medical Center, Grey School of Medicine and Tel Aviv University. University of Copenhagen. Karolinska Institutet. China, Israel, Denmark and Sweden Heart Failure ClinicsHeart Fail Clin 2026; 22: 361-370DOI: 10.1016/j.hfc.2026.02.009 AbstractPulmonary hypertension (PH) is a severe and oftentimes fatal disease with a high degree

The Role of Machine Learning and Artificial Intelligence in Drug Discovery and Clinical Care of Pulmonary Hypertension Read More »

Scroll to Top